1. Home
  2. AMPH vs EXPI Comparison

AMPH vs EXPI Comparison

Compare AMPH & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • EXPI
  • Stock Information
  • Founded
  • AMPH 1996
  • EXPI 2008
  • Country
  • AMPH United States
  • EXPI United States
  • Employees
  • AMPH N/A
  • EXPI N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • EXPI Real Estate
  • Sector
  • AMPH Health Care
  • EXPI Finance
  • Exchange
  • AMPH Nasdaq
  • EXPI Nasdaq
  • Market Cap
  • AMPH 1.1B
  • EXPI 1.3B
  • IPO Year
  • AMPH 2014
  • EXPI N/A
  • Fundamental
  • Price
  • AMPH $25.52
  • EXPI $8.71
  • Analyst Decision
  • AMPH Hold
  • EXPI Buy
  • Analyst Count
  • AMPH 5
  • EXPI 2
  • Target Price
  • AMPH $38.00
  • EXPI $10.75
  • AVG Volume (30 Days)
  • AMPH 521.8K
  • EXPI 1.3M
  • Earning Date
  • AMPH 05-07-2025
  • EXPI 07-30-2025
  • Dividend Yield
  • AMPH N/A
  • EXPI 2.29%
  • EPS Growth
  • AMPH N/A
  • EXPI N/A
  • EPS
  • AMPH 2.77
  • EXPI N/A
  • Revenue
  • AMPH $730,659,000.00
  • EXPI $4,579,524,000.00
  • Revenue This Year
  • AMPH $0.65
  • EXPI $2.85
  • Revenue Next Year
  • AMPH $5.26
  • EXPI $4.00
  • P/E Ratio
  • AMPH $9.23
  • EXPI N/A
  • Revenue Growth
  • AMPH 8.05
  • EXPI 4.83
  • 52 Week Low
  • AMPH $22.64
  • EXPI $6.90
  • 52 Week High
  • AMPH $53.96
  • EXPI $15.39
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 53.84
  • EXPI 56.46
  • Support Level
  • AMPH $25.13
  • EXPI $8.15
  • Resistance Level
  • AMPH $26.57
  • EXPI $8.96
  • Average True Range (ATR)
  • AMPH 0.71
  • EXPI 0.34
  • MACD
  • AMPH 0.17
  • EXPI 0.16
  • Stochastic Oscillator
  • AMPH 62.90
  • EXPI 66.94

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

Share on Social Networks: